Claim Missing Document
Check
Articles

Found 3 Documents
Search

Overview of Ear, Nose, and Throat Complaints of Covid 19 Inpatients at the University of Muhammadiyah Malang Hospital for the Period April 2021 to June 2021 Nimim Putri Zahara; Indra Setiawan; Jauhar Tajudin
Saintika Medika Vol. 18 No. 1 (2022): June 2022
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/sm.Vol18.SMUMM1.21604

Abstract

Covid-19 is spreading rapidly to other countries, and WHO confirmed it as a pandemic disease in March 2020. The virus enters directly to the surface of the mucosa with a high viral load, so it is clear that complaints in the nose and throat area are found. Covid-19 initially appears mainly in the airway with symptoms can be fever and dyspnea cough which can quickly switch to acute respiratory distress syndrome. RSU Universitas Muhammadiyah Malang has been one of the Covid-19 referral hospitals in East Java since April 2020, and there is no data on the description of nasal ear and throat complaints (ENT) in Covid-19 hospitalization patients at UMM Hospital. Mengetahui overview and overview of nose and throat ear complaints (ENT) experienced by Covid-19 hospitalized patients at UMM Hospital in the period April 2021 to June 2021. Descriptive retrospectively by taking data from the medical records of Covid-19 hospitalization patients of UMM Hospital in the period April to June 2021 with a total sampling method of 161 hospitalized patients with a confirmed diagnosis of Covid-19 with PCR examination during the period of April to June 2021. The study was conducted on 161 medical records with the results of 84 patients were men with 21 patients with severe degrees, 63 patients with moderate degrees, and 77 patients were women with 18 patients with severe degrees and 59 patients with moderate degrees. Mortality rates were obtained in as many as 26 (16%) with varying age ranges; 78 (48%) patients had comorbidities, with Diabetes mellitus as the highest comorbid among as many as 31 (40%) patients. Patients with ENT complaints were obtained among as many as 95 (60%) patients, and 66 (40%) patients were not accompanied by ENT complaints. The three most ENT complaints were colds (rhinitis) in as many as 62 (39%) patients, anosmia hyposmia in as many as 26 (16%) patients, and throat pain in as many as 22 (14%) patients. Most patients were men with moderate degrees, with mortality rates of 16% and 48% of patients accompanied by comorbidities. The most ENT complaints were rhinitis 39%, anosmia-hyposmia 16%, and throat pain in as much as 14% of patients.
Hubungan Antara Kebiasaan Merokok Dengan Perjalanan Penyakit Rhinitis Sabilarrusydi; Manuel Umbu Madiaha; Nimim Putri Zahara; Bambang Mulyawan
ARTERI : Jurnal Ilmu Kesehatan Vol 4 No 2 (2023): Februari
Publisher : Puslitbang Sinergis Asa Professional

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37148/arteri.v4i2.248

Abstract

One of the rhinitis diseases is allergic rhinitis (RA) which is a condition of hypersensitivity of the nasal mucosa due to the appearance of Ig E characterized by symptoms of sneezing, itchy nose, runny nose and nasal congestion after exposure to allergens. Release of mediators gives rise to a fast phase response and a slow phase response. The habit of smoking is mostly carried out by people in the world and the number of smokers in Indonesia is ranked seventh in the world. This article was written using a systematic review model, by searching for articles from reputable journals, using the PUBMED search engine which then obtained 30 articles. Allergic rhinitis has a very complex pathophysiology, from the initial phase of the allergic response to the end. Many inflammatory cells, including macrophages, mast cells, B cells, T cells, eosinophils, and CD4+, sneak up on the lining of the nose after exposure to allergens. The cross-linking of IgE bound to mast cells by allergens, in turn, triggers the release of mediators, including leukotrienes and histamine which causes arteriolar dilation, increased vascular permeability, itching, mucus secretion, rhinorrhea, and smooth muscle contraction in the lungs. Increased total IgE levels and specific IgE levels can be caused by smoking status smoking. The severity of patients diagnosed with allergic rhinitis can be influenced by smoking habits or status. Smoking does not cause allergic rhinitis, but smoking makes allergic rhinitis symptoms worse.
A Relationship ENT Complaints with Severity and Length of Hospitalization of COVID-19 patients at UMM Hospital Nimim Putri Zahara; Rahma Rindradi
Saintika Medika Vol. 19 No. 1 (2023): June 2023
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/sm.Vol19.SMUMM1.26188

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 ). Most COVID-19 patients have no symptoms, but if they have complaints or symptoms that are most often felt are fever, cough, anorexia, muscle pain, difficulty of breathing, malaise. Complaints of hyposmia and dysgeusia are early complaints found in COVID-19 patients, which can appear in the first 5-7 days. This can be used to help early detection of COVID-19 cases so that it can break the chain of transmission of COVID-19. This study is an analytic descriptive study. This research was conducted from April to June 2021, in the COVID-19 inpatient room at UMM Hospital. Data analysis in this study used Chi square. All respondents in this study complained coughing, namely 90 respondents. Other complaints include rhinitis, anosmia, sore throat, dysgeusia and vertigo. From the results of the analysis between ENT complaints severity of COVID-19 patient, the value of p=0.231 (p>0.05) was obtained and length of hospitalization has p value 0.116 (p>0.05). In this study, it can be concluded that there is no statistically significant relationship between ENT complaints with the severity and length of hospitalization of COVID-19 patients that treated at RSUMM.